ENTRY       D00742                      Drug
NAME        Etanercept (USAN/INN);
            Etanercept (genetical recombination) (JAN);
            Etanercept (genetical recombination) [Etanercept biosimilar 1] (JAN);
            Etanercept (genetical recombination) [Etanercept biosimilar 2] (JAN);
            Enbrel (TN)
PRODUCT     ENBREL (Immunex Corporation)
SEQUENCE    LPAQVAFTPY APEPGSTCRL REYYDQTAQM CCSKCSPGQH AKVFCTKTSD TVCDSCEDST
            YTQLWNWVPE CLSCGSRCSS DQVETQACTR EQNRICTCRP GWYCALSKQE GCRLCAPLRK
            CRPGFGVARP GTETSDVVCK PCAPGTFSNT TSSTDICRPH QICNVVAIPG NASMDAVCTS
            TSPTRSMAPG AVHLPQPVST RSQHTQPTPE PSTAPSTSFL LPMGPSPPAE GSTGDEPKSC
            DKTHTCPPCP APELLGGPSV FLFPPKPKDT LMISRTPEVT CVVVDVSHED PEVKFNWYVD
            GVEVHNAKTK PREEQYNSTY RVVSVLTVLH QDWLNGKEYK CKVSNKALPA PIEKTISKAK
            GQPREPQVYT LPPSREEMTK NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS
            DGSFFLYSKL TVDKSRWQQG NVFSCSVMHE ALHNHYTQKS LSLSPGK
  TYPE      Peptide
CLASS       Anti-inflammatory
             DG01985  Disease modifying anti-rheumatic drug (DMARD)
              DG01936  TNF inhibitor
REMARK      Same as: C07897
            Therapeutic category: 3999
            ATC code: L04AB01
            Product: D00742<JP/US>
EFFICACY    Antirheumatic, TNF receptor antagonist
  DISEASE   Rheumatoid arthritis [DS:H00630]
            Polyarticular juvenile idiopathic arthritis [DS:H01672]
            Psoriatic arthritis [DS:H01507]
            Ankylosing spondylitis [DS:H01674]
            Plaque psoriasis [DS:H01656]
COMMENT     recombinant fusion protein
            To decrease signs and symptoms of rheumatoid arthritis
TARGET      TNF (TNFA, TNFSF2) [HSA:7124] [KO:K03156]
            LTA (TNFB, TNFSF1) [HSA:4049] [KO:K05468]
  PATHWAY   hsa04010(7124)  MAPK signaling pathway
            hsa04060(4049+7124)  Cytokine-cytokine receptor interaction
            hsa04064(4049+7124)  NF-kappa B signaling pathway
            hsa04210(7124)  Apoptosis
            hsa04350(7124)  TGF-beta signaling pathway
            hsa04380(7124)  Osteoclast differentiation
            hsa04612(7124)  Antigen processing and presentation
            hsa04920(7124)  Adipocytokine signaling pathway
            hsa05323(7124)  Rheumatoid arthritis
INTERACTION  
STR_MAP     map07050  Antirheumatics - DMARDs and biological agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L04 IMMUNOSUPPRESSANTS
               L04A IMMUNOSUPPRESSANTS
                L04AB Tumor necrosis factor alpha (TNF-alpha) inhibitors
                 L04AB01 Etanercept
                  D00742  Etanercept (USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Immunological Agents
              Immunosuppressants
               Tumor Necrosis Factor (TNF) Blockers
                Etanercept
                 D00742  Etanercept (USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               399  Miscellaneous
                3999  Others
                 D00742  Etanercept (USAN/INN); Etanercept (genetical recombination) (JAN); Etanercept (genetical recombination) [Etanercept biosimilar 1] (JAN); Etanercept (genetical recombination) [Etanercept biosimilar 2] (JAN)
            Drug groups [BR:br08330]
             Anti-inflammatory
              DG01985  Disease modifying anti-rheumatic drug (DMARD)
               DG01936  TNF inhibitor
                D00742  Etanercept
            Drug classes [BR:br08332]
             Immunological agent
              DG01936  TNF inhibitor
               D00742  Etanercept
             Antirheumatic agent
              DG01985  Disease modifying anti-rheumatic drug (DMARD)
               D00742  Etanercept
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Tumor necrosis factors
                TNF (TNFA, TNFSF2)
                 D00742  Etanercept (USAN/INN) &lt;JP/US&gt;
                LTA (TNFB, TNFSF1)
                 D00742  Etanercept (USAN/INN) &lt;JP/US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D00742
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D00742
DBLINKS     CAS: 185243-69-0
            PubChem: 7847807
            ChEBI: 4875
            NIKKAJI: J2.104.917D
///
